Study Title: A Phase 1/2, Open-Label, Dose-Escalation, Dose-Expansion Study of DSP-5336 in Adult Patients with Acute Leukemia and Other Selected Hematologic Malignancies, with and without Mixed Lineage Leukemia (MLL) rearrangement or Nucleophosmin 1 (NPM1) Mutation
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Praneeth Baratam, at baratamp@musc.edu.Study Coordinator, Julia Smith, at smijuli1@musc.edu.Trial opened at the following institutions: Medical University of South Carolina